Up a level |
Carlsson, Emil, Quist, Alexandra, Davies, Jennifer C, Midgley, Angela, Smith, Eve MD, Bruce, Ian N, Beresford, Michael W ORCID: 0000-0002-5400-9911 and Hedrich, Christian M ORCID: 0000-0002-1295-6179
(2022)
Longitudinal analysis of urinary proteins in lupus nephritis – A pilot study.
Clinical Immunology, 236.
p. 108948.
Butler, Christopher C, Hobbs, FD Richard, Gbinigie, Oghenekome A, Rahman, Najib M, Hayward, Gail, Richards, Duncan B, Dorward, Jienchi, Lowe, David M, Standing, Joseph F, Breuer, Judith et al (show 47 more authors)
(2023)
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial.
LANCET, 401 (10373).
pp. 281-293.
Davies, Jennifer C, Midgley, Angela, Carlsson, Emil, Donohue, Sean, Bruce, Ian N, Beresford, Michael W ORCID: 0000-0002-5400-9911 and Hedrich, Christian M ORCID: 0000-0002-1295-6179
(2020)
Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment.
RMD OPEN, 6 (2).
e001257-.